Related Experiment Video
Updated: Feb 17, 2026
Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines
Published on: September 10, 2014
Isolation and characterization of mesenchymal stem cells and its antitumor application on ovarian cancer cell line
Farideh Mohammadian1, Babak Negahdari2
1a Department of Medical Biotechnology , Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences , Tabriz , Iran.
Abstract:
The molecular interaction network of Oct-4 (POU5F1) and NANOG connected to regulation and growth of mesenchymal stem cells (MSCs) were supplemented with information of miRNA to find an important micro-RNAs and supplemented molecular interaction network. Following co-culturing of Bone marrow mesenchymal stem cells (BMMSCs) with SKOV3 ovarian cancer cell lines and undifferentiated BMMSCs, MTT was analyzed for cell cytotoxicity. The analyses of the expression of miRNA were performed either after oesteogenesis (hsa-miR-34 and hsa-miR-335) or chondrogenic (hsa-miR-145 and hsa-miR-455) differentiation. This molecular interaction network was imaged in using software. The results from these findings gave an understanding of the main molecular mechanisms regulating MSCs therapeutic activity and their undifferentiated state maintenance. We recommend that the downregulation of miR-335 is crucial role for tissue homeostasis.
Insights
Investigating microRNAs (miRNAs) in mesenchymal stem cells (MSCs) revealed key regulators of their growth and therapeutic potential. Downregulation of miR-335 is crucial for maintaining tissue homeostasis and MSC function.
Area of Science:
- Biochemistry
- Molecular Biology
- Stem Cell Biology
Background:
- Mesenchymal stem cells (MSCs) are crucial for tissue repair and have therapeutic potential.
- The molecular interactions governing MSC regulation, particularly involving Oct-4 (POU5F1) and NANOG, are complex.
- MicroRNAs (miRNAs) play significant roles in cellular processes, including stem cell differentiation and function.
Purpose of the Study:
- To elucidate the molecular interaction network regulating mesenchymal stem cells (MSCs) and their therapeutic activity.
- To identify key microRNAs (miRNAs) involved in MSC regulation and differentiation.
- To understand the role of specific miRNAs in maintaining the undifferentiated state and therapeutic potential of MSCs.
Main Methods:
- Construction and visualization of a molecular interaction network involving Oct-4 (POU5F1), NANOG, and miRNAs.
- Co-culturing of Bone marrow mesenchymal stem cells (BMMSCs) with SKOV3 ovarian cancer cell lines.
- MTT assay for cell cytotoxicity analysis.
- Analysis of miRNA expression (hsa-miR-34, hsa-miR-335, hsa-miR-145, hsa-miR-455) following osteogenic and chondrogenic differentiation.
Main Results:
- A supplemented molecular interaction network was established, incorporating crucial miRNAs.
- Cytotoxicity analysis indicated interactions between BMMSCs and SKOV3 cells.
- Specific miRNAs (hsa-miR-34, hsa-miR-335, hsa-miR-145, hsa-miR-455) were identified in relation to MSC differentiation.
- The study provided insights into molecular mechanisms regulating MSC therapeutic activity and stemness.
Conclusions:
- The molecular network provides a deeper understanding of MSC regulation.
- Downregulation of hsa-miR-335 is identified as critical for maintaining tissue homeostasis.
- These findings contribute to understanding MSC behavior for therapeutic applications.
